Search research articles
Contact Us
Filters
Showing results (31-40 of 58) with videos related to
Page
of 6
Sort By:
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists
|
January 7, 2026
Effect of a multifaceted hospital fluid conservation approach to intravenous fluid shortages on patient outcomes
Obert Xu, Peter Graven, Siouxzanna Downs, et al.
Journal of Crohn'S & Colitis
|
March 22, 2024
Spondyloarthritis in First-Degree Relatives and Spouses of Patients with Inflammatory Bowel Disease: A Nationwide Population-based Cohort Study from Sweden
Sarita Shrestha, Judith S Brand, Mehdi Osooli, et al.
BJS Open
|
August 13, 2025
Outcomes of inflammatory bowel disease in patients with obesity following bariatric surgery: propensity score-matched cohort study
Erik Stenberg, Åsa H Everhov, Jonas Söderling, et al.
Scandinavian Journal of Gastroenterology
|
April 26, 2025
Adult-onset inflammatory bowel disease and the risk of venous thromboembolism - a Swedish nationwide cohort study 2007-2021
Gabriella Bröms, Anders Forss, Julia Eriksson, et al.
Scandinavian Journal of Gastroenterology
|
August 20, 2021
Clinical effectiveness of golimumab in ulcerative colitis: a prospective multicentre study based on the Swedish IBD Quality Register, SWIBREG
Carl Eriksson, Isabella Visuri, Lina Vigren, et al.
Scandinavian Journal of Gastroenterology
|
October 25, 2018
Clinical effectiveness of golimumab in Crohn's disease: an observational study based on the Swedish National Quality Registry for Inflammatory Bowel Disease (SWIBREG)
Sara Rundquist, Carl Eriksson, Linda Nilsson, et al.
Critical Care Explorations
|
July 23, 2020
Statewide Real-Time Tracking of Beds and Ventilators During Coronavirus Disease 2019 and Beyond
Matthias Johannes Merkel, Renee Edwards, Joe Ness, et al.
Alimentary Pharmacology & Therapeutics
|
August 23, 2021
Editorial: infliximab or adalimumab as first- or second-line anti-TNF-conflicting evidence-authors' reply
Isabella Visuri, Carl Eriksson, Ola Olén, et al.
Alimentary Pharmacology & Therapeutics
|
July 21, 2021
Predictors of drug survival: A cohort study comparing anti-tumour necrosis factor agents using the Swedish inflammatory bowel disease quality register
Isabella Visuri, Carl Eriksson, Ola Olén, et al.
United European Gastroenterology Journal
|
July 14, 2022
Ustekinumab treatment in ulcerative colitis: Real-world data from the Swedish inflammatory bowel disease quality register
Joel Thunberg, Olle Björkqvist, Charlotte R H Hedin, et al.
Page
of 6
Search research articles
Search
Showing results (31-40 of 58) with videos related to
Sort By:
Page
of 6
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists
|
January 7, 2026
Effect of a multifaceted hospital fluid conservation approach to intravenous fluid shortages on patient outcomes
Obert Xu, Peter Graven, Siouxzanna Downs, et al.
Journal of Crohn'S & Colitis
|
March 22, 2024
Spondyloarthritis in First-Degree Relatives and Spouses of Patients with Inflammatory Bowel Disease: A Nationwide Population-based Cohort Study from Sweden
Sarita Shrestha, Judith S Brand, Mehdi Osooli, et al.
BJS Open
|
August 13, 2025
Outcomes of inflammatory bowel disease in patients with obesity following bariatric surgery: propensity score-matched cohort study
Erik Stenberg, Åsa H Everhov, Jonas Söderling, et al.
Scandinavian Journal of Gastroenterology
|
April 26, 2025
Adult-onset inflammatory bowel disease and the risk of venous thromboembolism - a Swedish nationwide cohort study 2007-2021
Gabriella Bröms, Anders Forss, Julia Eriksson, et al.
Scandinavian Journal of Gastroenterology
|
August 20, 2021
Clinical effectiveness of golimumab in ulcerative colitis: a prospective multicentre study based on the Swedish IBD Quality Register, SWIBREG
Carl Eriksson, Isabella Visuri, Lina Vigren, et al.
Scandinavian Journal of Gastroenterology
|
October 25, 2018
Clinical effectiveness of golimumab in Crohn's disease: an observational study based on the Swedish National Quality Registry for Inflammatory Bowel Disease (SWIBREG)
Sara Rundquist, Carl Eriksson, Linda Nilsson, et al.
Critical Care Explorations
|
July 23, 2020
Statewide Real-Time Tracking of Beds and Ventilators During Coronavirus Disease 2019 and Beyond
Matthias Johannes Merkel, Renee Edwards, Joe Ness, et al.
Alimentary Pharmacology & Therapeutics
|
August 23, 2021
Editorial: infliximab or adalimumab as first- or second-line anti-TNF-conflicting evidence-authors' reply
Isabella Visuri, Carl Eriksson, Ola Olén, et al.
Alimentary Pharmacology & Therapeutics
|
July 21, 2021
Predictors of drug survival: A cohort study comparing anti-tumour necrosis factor agents using the Swedish inflammatory bowel disease quality register
Isabella Visuri, Carl Eriksson, Ola Olén, et al.
United European Gastroenterology Journal
|
July 14, 2022
Ustekinumab treatment in ulcerative colitis: Real-world data from the Swedish inflammatory bowel disease quality register
Joel Thunberg, Olle Björkqvist, Charlotte R H Hedin, et al.
Page
of 6